Steroid Use in Non-RSV Bronchiolitis

Summary

The proposed study is a pilot randomized control trial to determine the efficacy of dexamethasone use in hospitalized children who are less than 2 years of age with non-respiratory syncytial virus (RSV) bronchiolitis admitted to the University of Pittsburgh Medical Center (UPMC) Children's Hospital of Pittsburgh from February 1 to May 31, 2022. It is hypothesized that the use of standard airway-dose steroids (0.6mg/kg dexamethasone) will improve the clinical outcome of children hospitalized for non-RSV bronchiolitis, which will be evident by decreased length of stay.

Timeline

Start

2020-02-03

Primary completion

2022-12-31

Completion

2022-12-31

Outcome

Outcome not reported

Stopped: “COVID19-pandemic, RSV surge”

Drugs

Indications